Description
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Cas No. | 878419-78-4 |
|---|---|
| Purity | ≥98% |
| Formula | C14H10F3N5O2 |
| Formula Wt. | 337.26 |
| IUPAC Name | 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
| Solubility | DMSO: 11.5 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Gotoh Y, Doi A, Furuta E, et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator. J Antibiot (Tokyo). 2010 Mar;63(3):127-34. PMID: 20111065.
ACE inhibitor.
H+/K+ ATPase and ROCK-2 inhibitor.
Pheniramine derivative; histamine H1 and mAChR ...
ALK and IGF-1R inhibitor.
Macrolide; F1F0 ATP synthase inhibitor.
Histamine H1 antagonist.
Synthetic kahweol derivative.
Glucocorticoid
ITC, used as chiral agent.
Nitrogen mustard, DNA alkylator.
Dibenzofuran produced by lichens.
Aromatic retinoid; RAR, RXR agonist.
Thienylbutyl ITC analog.
Cathepsin K inhibitor.
Butyrophenone; σ2 agonist, α1-adrenergic, D2,...
Roscovitine analog; CDK inhibitor.
CB1 receptor antagonist/ inverse agonist.
Impurity of rapamycin
Endogenous cardiomodulatory peptide; NPR-A agon...
Non-selective CB receptor agonist.